BindingDB logo
myBDB logout

Patent code US10738026

Compile Data Set for Download or QSAR
Found 17 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457084
PNG
((2S,3R)-2,3-dihydroxy-3-(6-(5- (4-(trifluoromethyl...)
Show SMILES NC(=O)[C@@H](O)[C@H](O)c1cccc(n1)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F |r|
Show InChI InChI=1S/C24H22F3N3O3/c25-24(26,27)16-9-7-14(8-10-16)17-4-1-3-15-13-30(12-11-18(15)17)20-6-2-5-19(29-20)21(31)22(32)23(28)33/h1-10,21-22,31-32H,11-13H2,(H2,28,33)/t21-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
51n/an/an/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
On the day of experimentation, cells are prepared by removing media and digesting with appropriate enzymes to suspend cells in external solution.Whol...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457094
PNG
((S)-6-(1,2-dihydroxyethyl)-4- (5-(4-(trifluorometh...)
Show SMILES NC(=O)c1cc(cc(n1)[C@H](O)CO)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F |r|
Show InChI InChI=1S/C24H22F3N3O3/c25-24(26,27)16-6-4-14(5-7-16)18-3-1-2-15-12-30(9-8-19(15)18)17-10-20(22(32)13-31)29-21(11-17)23(28)33/h1-7,10-11,22,31-32H,8-9,12-13H2,(H2,28,33)/t22-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
232n/an/an/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
On the day of experimentation, cells are prepared by removing media and digesting with appropriate enzymes to suspend cells in external solution.Whol...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457086
PNG
((S)-6-((1-amino-1-oxopropan- 2-yl)amino)-2-(5-(3- ...)
Show SMILES C[C@H](Nc1cc(nc(n1)N1CCc2c(C1)cccc2-c1cccc(c1)C(F)(F)F)C(N)=O)C(N)=O |r|
Show InChI InChI=1S/C24H23F3N6O2/c1-13(21(28)34)30-20-11-19(22(29)35)31-23(32-20)33-9-8-18-15(12-33)5-3-7-17(18)14-4-2-6-16(10-14)24(25,26)27/h2-7,10-11,13H,8-9,12H2,1H3,(H2,28,34)(H2,29,35)(H,30,31,32)/t13-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
240n/an/an/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
On the day of experimentation, cells are prepared by removing media and digesting with appropriate enzymes to suspend cells in external solution.Whol...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457096
PNG
((R)-6-(1,2-dihydroxyethyl)-4- (5-(4-(trifluorometh...)
Show SMILES NC(=O)c1cc(cc(n1)[C@@H](O)CO)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F |r|
Show InChI InChI=1S/C24H22F3N3O3/c25-24(26,27)16-6-4-14(5-7-16)18-3-1-2-15-12-30(9-8-19(15)18)17-10-20(22(32)13-31)29-21(11-17)23(28)33/h1-7,10-11,22,31-32H,8-9,12-13H2,(H2,28,33)/t22-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
257n/an/an/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
On the day of experimentation, cells are prepared by removing media and digesting with appropriate enzymes to suspend cells in external solution.Whol...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457080
PNG
((S)-6-((1-amino-1-oxopropan- 2-yl)amino)-2-(5-(4- ...)
Show SMILES C[C@H](Nc1cc(nc(n1)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F)C(N)=O)C(N)=O |r|
Show InChI InChI=1S/C24H23F3N6O2/c1-13(21(28)34)30-20-11-19(22(29)35)31-23(32-20)33-10-9-18-15(12-33)3-2-4-17(18)14-5-7-16(8-6-14)24(25,26)27/h2-8,11,13H,9-10,12H2,1H3,(H2,28,34)(H2,29,35)(H,30,31,32)/t13-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
317n/an/an/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
On the day of experimentation, cells are prepared by removing media and digesting with appropriate enzymes to suspend cells in external solution.Whol...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457088
PNG
(N-(1,2,4-thiadiazol-5-yl)-6-(5- (4-(trifluoromethy...)
Show SMILES FC(F)(F)c1ccc(cc1)-c1cccc2CN(CCc12)c1cccc(n1)S(=O)(=O)Nc1ncns1
Show InChI InChI=1S/C23H18F3N5O2S2/c24-23(25,26)17-9-7-15(8-10-17)18-4-1-3-16-13-31(12-11-19(16)18)20-5-2-6-21(29-20)35(32,33)30-22-27-14-28-34-22/h1-10,14H,11-13H2,(H,27,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
535n/an/an/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
On the day of experimentation, cells are prepared by removing media and digesting with appropriate enzymes to suspend cells in external solution.Whol...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457084
PNG
((2S,3R)-2,3-dihydroxy-3-(6-(5- (4-(trifluoromethyl...)
Show SMILES NC(=O)[C@@H](O)[C@H](O)c1cccc(n1)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F |r|
Show InChI InChI=1S/C24H22F3N3O3/c25-24(26,27)16-9-7-14(8-10-16)17-4-1-3-15-13-30(12-11-18(15)17)20-6-2-5-19(29-20)21(31)22(32)23(28)33/h1-10,21-22,31-32H,11-13H2,(H2,28,33)/t21-,22+/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 251n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457088
PNG
(N-(1,2,4-thiadiazol-5-yl)-6-(5- (4-(trifluoromethy...)
Show SMILES FC(F)(F)c1ccc(cc1)-c1cccc2CN(CCc12)c1cccc(n1)S(=O)(=O)Nc1ncns1
Show InChI InChI=1S/C23H18F3N5O2S2/c24-23(25,26)17-9-7-15(8-10-17)18-4-1-3-16-13-31(12-11-19(16)18)20-5-2-6-21(29-20)35(32,33)30-22-27-14-28-34-22/h1-10,14H,11-13H2,(H,27,28,30)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 291n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457080
PNG
((S)-6-((1-amino-1-oxopropan- 2-yl)amino)-2-(5-(4- ...)
Show SMILES C[C@H](Nc1cc(nc(n1)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F)C(N)=O)C(N)=O |r|
Show InChI InChI=1S/C24H23F3N6O2/c1-13(21(28)34)30-20-11-19(22(29)35)31-23(32-20)33-10-9-18-15(12-33)3-2-4-17(18)14-5-7-16(8-6-14)24(25,26)27/h2-8,11,13H,9-10,12H2,1H3,(H2,28,34)(H2,29,35)(H,30,31,32)/t13-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 428n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457094
PNG
((S)-6-(1,2-dihydroxyethyl)-4- (5-(4-(trifluorometh...)
Show SMILES NC(=O)c1cc(cc(n1)[C@H](O)CO)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F |r|
Show InChI InChI=1S/C24H22F3N3O3/c25-24(26,27)16-6-4-14(5-7-16)18-3-1-2-15-12-30(9-8-19(15)18)17-10-20(22(32)13-31)29-21(11-17)23(28)33/h1-7,10-11,22,31-32H,8-9,12-13H2,(H2,28,33)/t22-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 502n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457083
PNG
(6-(5-(4-(trifluoromethyl)- phenyl)-3,4-dihydro- is...)
Show SMILES NC(=O)c1cccc(n1)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F
Show InChI InChI=1S/C22H18F3N3O/c23-22(24,25)16-9-7-14(8-10-16)17-4-1-3-15-13-28(12-11-18(15)17)20-6-2-5-19(27-20)21(26)29/h1-10H,11-13H2,(H2,26,29)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 987n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457086
PNG
((S)-6-((1-amino-1-oxopropan- 2-yl)amino)-2-(5-(3- ...)
Show SMILES C[C@H](Nc1cc(nc(n1)N1CCc2c(C1)cccc2-c1cccc(c1)C(F)(F)F)C(N)=O)C(N)=O |r|
Show InChI InChI=1S/C24H23F3N6O2/c1-13(21(28)34)30-20-11-19(22(29)35)31-23(32-20)33-9-8-18-15(12-33)5-3-7-17(18)14-4-2-6-16(10-14)24(25,26)27/h2-7,10-11,13H,8-9,12H2,1H3,(H2,28,34)(H2,29,35)(H,30,31,32)/t13-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.52E+3n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457096
PNG
((R)-6-(1,2-dihydroxyethyl)-4- (5-(4-(trifluorometh...)
Show SMILES NC(=O)c1cc(cc(n1)[C@@H](O)CO)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F |r|
Show InChI InChI=1S/C24H22F3N3O3/c25-24(26,27)16-6-4-14(5-7-16)18-3-1-2-15-12-30(9-8-19(15)18)17-10-20(22(32)13-31)29-21(11-17)23(28)33/h1-7,10-11,22,31-32H,8-9,12-13H2,(H2,28,33)/t22-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.54E+3n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457092
PNG
((S)-6-((1-amino-1-oxopropan- 2-yl)amino)-2-(5-cycl...)
Show SMILES C[C@H](Nc1cc(nc(n1)N1CCc2c(C1)cccc2C1CCCCC1)C(N)=O)C(N)=O |r|
Show InChI InChI=1S/C23H30N6O2/c1-14(21(24)30)26-20-12-19(22(25)31)27-23(28-20)29-11-10-18-16(13-29)8-5-9-17(18)15-6-3-2-4-7-15/h5,8-9,12,14-15H,2-4,6-7,10-11,13H2,1H3,(H2,24,30)(H2,25,31)(H,26,27,28)/t14-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.20E+3n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457082
PNG
((S)-6-((1-amino-1-oxopropan- 2-yl)amino)-2-(5-(2- ...)
Show SMILES C[C@H](Nc1cc(nc(n1)N1CCc2c(C1)cccc2-c1ccccc1C(F)(F)F)C(N)=O)C(N)=O |r|
Show InChI InChI=1S/C24H23F3N6O2/c1-13(21(28)34)30-20-11-19(22(29)35)31-23(32-20)33-10-9-15-14(12-33)5-4-7-16(15)17-6-2-3-8-18(17)24(25,26)27/h2-8,11,13H,9-10,12H2,1H3,(H2,28,34)(H2,29,35)(H,30,31,32)/t13-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.35E+3n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457087
PNG
((S)-6-((1-amino-1-oxopropan- 2-yl)amino)-2-(5-(cyc...)
Show SMILES C[C@H](Nc1cc(nc(n1)N1CCc2c(C1)cccc2C1=CCCCC1)C(N)=O)C(N)=O |r,t:22|
Show InChI InChI=1S/C23H28N6O2/c1-14(21(24)30)26-20-12-19(22(25)31)27-23(28-20)29-11-10-18-16(13-29)8-5-9-17(18)15-6-3-2-4-7-15/h5-6,8-9,12,14H,2-4,7,10-11,13H2,1H3,(H2,24,30)(H2,25,31)(H,26,27,28)/t14-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.84E+3n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
Sodium channel protein type 9 subunit alpha


(Homo sapiens (Human))
BDBM457081
PNG
((S)-6-((1-amino-1-oxopropan- 2-yl)amino)-2-(5-(5- ...)
Show SMILES C[C@H](Nc1cc(nc(n1)N1CCc2c(C1)cccc2-c1ccc(cn1)C(F)(F)F)C(N)=O)C(N)=O |r|
Show InChI InChI=1S/C23H22F3N7O2/c1-12(20(27)34)30-19-9-18(21(28)35)31-22(32-19)33-8-7-15-13(11-33)3-2-4-16(15)17-6-5-14(10-29-17)23(24,25)26/h2-6,9-10,12H,7-8,11H2,1H3,(H2,27,34)(H2,28,35)(H,30,31,32)/t12-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+4n/an/an/an/an/an/a



Purdue Pharma L.P.

US Patent


Assay Description
The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th...


US Patent US10738026 (2020)


BindingDB Entry DOI: 10.7270/Q2SF307H
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%